Posted by Defense World Staff on Feb 22nd, 2026
Equities research analysts at Barclays initiated coverage on shares of Amgen (NASDAQ:AMGN – Get Free Report) in a research report issued to clients and investors on Friday,Benzinga reports. The firm set an “equal weight”...
More of this article »